2-27092384-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006488.3(KHK):c.145G>A(p.Val49Ile) variant causes a missense change. The variant allele was found at a frequency of 0.369 in 1,613,034 control chromosomes in the GnomAD database, including 113,460 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.37 ( 10529 hom., cov: 34)
Exomes 𝑓: 0.37 ( 102931 hom. )
Consequence
KHK
NM_006488.3 missense
NM_006488.3 missense
Scores
4
14
Clinical Significance
Conservation
PhyloP100: 4.25
Genes affected
KHK (HGNC:6315): (ketohexokinase) This gene encodes ketohexokinase that catalyzes conversion of fructose to fructose-1-phosphate. The product of this gene is the first enzyme with a specialized pathway that catabolizes dietary fructose. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=2.3898482E-4).
BP6
Variant 2-27092384-G-A is Benign according to our data. Variant chr2-27092384-G-A is described in ClinVar as [Benign]. Clinvar id is 335482.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.5 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KHK | NM_006488.3 | c.145G>A | p.Val49Ile | missense_variant | 2/8 | ENST00000260598.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KHK | ENST00000260598.10 | c.145G>A | p.Val49Ile | missense_variant | 2/8 | 2 | NM_006488.3 | P3 | |
KHK | ENST00000260599.11 | c.145G>A | p.Val49Ile | missense_variant | 2/8 | 1 | A1 | ||
KHK | ENST00000429697.2 | c.145G>A | p.Val49Ile | missense_variant | 2/9 | 5 | |||
KHK | ENST00000490823.5 | n.493G>A | non_coding_transcript_exon_variant | 4/10 | 5 |
Frequencies
GnomAD3 genomes AF: 0.365 AC: 55547AN: 152056Hom.: 10514 Cov.: 34
GnomAD3 genomes
AF:
AC:
55547
AN:
152056
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.386 AC: 96856AN: 250738Hom.: 20412 AF XY: 0.377 AC XY: 51191AN XY: 135684
GnomAD3 exomes
AF:
AC:
96856
AN:
250738
Hom.:
AF XY:
AC XY:
51191
AN XY:
135684
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.370 AC: 540369AN: 1460860Hom.: 102931 Cov.: 45 AF XY: 0.368 AC XY: 267576AN XY: 726820
GnomAD4 exome
AF:
AC:
540369
AN:
1460860
Hom.:
Cov.:
45
AF XY:
AC XY:
267576
AN XY:
726820
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.365 AC: 55581AN: 152174Hom.: 10529 Cov.: 34 AF XY: 0.365 AC XY: 27182AN XY: 74386
GnomAD4 genome
AF:
AC:
55581
AN:
152174
Hom.:
Cov.:
34
AF XY:
AC XY:
27182
AN XY:
74386
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1322
ALSPAC
AF:
AC:
1472
ESP6500AA
AF:
AC:
1399
ESP6500EA
AF:
AC:
3231
ExAC
AF:
AC:
45711
Asia WGS
AF:
AC:
1061
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Essential fructosuria Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;.
MutationTaster
Benign
P;P
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
P;B;.
Vest4
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at